Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Ocugen Inc (NQ: OCGN ) 1.740 -0.070 (-3.87%) Streaming Delayed Price Updated: 12:45 PM EDT, Jul 10, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Ocugen Inc < Previous 1 2 3 4 5 6 7 8 9 ... 31 32 Next > ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - OCGN April 15, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal ROSEN, SKILLED INVESTOR COUNSEL, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - OCGN April 14, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - OCGN April 13, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - OCGN April 13, 2024 WHY: NEW YORK, NY - (NewMediaWire) - April 13, 2024 - Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Ocugen,... Via TheNewswire.com Topics Lawsuit Exposures Financial Legal OCGN Stock Alert: Why Is Ocugen Up 20% Today? April 05, 2024 With Ocugen receiving a green light to move ahead with a key retinal therapeutic, OCGN stock jumped on the positive implications. Via InvestorPlace Why Ocugen Shares Are Popping Off April 03, 2024 Ocugen shares are trading higher by 14% during Wednesday's session. The company provided an update on its business activities and financial status for 2023. Via Benzinga ROSEN, A LONGSTANDING LAW FIRM, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - OCGN April 12, 2024 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal ROSEN, A LONGSTANDING LAW FIRM, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - OCGN April 12, 2024 WHY: NEW YORK, NY - (NewMediaWire) - April 12, 2024 - Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Ocugen,... Via TheNewswire.com Topics Lawsuit Exposures Financial Legal INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Ocugen, Inc. (OCGN) on Behalf of Investors April 12, 2024 From Law Offices of Howard G. Smith Via Business Wire Ocugen to Participate in Fireside Chat at the Emerging Growth Virtual Healthcare Equity Conference, Presented by Noble Capital Markets April 12, 2024 From Ocugen Via GlobeNewswire OCUGEN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Ocugen, Inc. and Encourages Investors to Contact the Firm April 11, 2024 From Bragar Eagel & Squire Via GlobeNewswire SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Ocugen, Inc. with Losses to Contact the Firm April 11, 2024 From Schall Law Via GlobeNewswire Stockholder Alert: Robbins LLP Informs Investors of the Class Action Filed Against Ocugen, Inc. (OCGN) April 11, 2024 From Robbins LLP Via GlobeNewswire EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Ocugen, Inc. Incorporated Investors – OCGN April 11, 2024 From Rosen Law Firm Via Business Wire The Law Offices of Frank R. Cruz Announces Investigation of Ocugen, Inc. (OCGN) on Behalf of Investors April 10, 2024 From The Law Offices of Frank R. Cruz Via Business Wire Ocugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to the Approval Pathway for OCU400—Modifier Gene Therapy for Broad Retinitis Pigmentosa Indication April 10, 2024 From Ocugen Via GlobeNewswire OCUGEN LOSS ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages Ocugen, Inc. Investors to Inquire About Securities Class Action Investigation – OCGN April 09, 2024 From The Rosen Law Firm, P.A. Via Business Wire Why Is Auddia (AUUD) Stock Up 192% Today? April 08, 2024 Auddia stock is taking off on Monday with heavy trading of AUUD stock after the company received a new AI tech patent. Via InvestorPlace Topics Artificial Intelligence Exposures Artificial Intelligence Why Ocugen Shares Are Trading Higher April 08, 2024 Ocugen shares are trading higher by 7.7% during Monday's session. The company announced U.S. FDA clearance of the IND amendment to initiate a Phase 3 clinical trial of OCU400. Via Benzinga Exposures Product Safety Why Is Ocugen (OCGN) Stock Up 7% Today? April 08, 2024 Ocugen is returning to its eye treatment roots after a brief life as a Covid-19 vaccine meme stock in 2021 delivered OCGN stock no results. Via InvestorPlace Exposures COVID-19 12 Health Care Stocks Moving In Monday's Pre-Market Session April 08, 2024 Via Benzinga Ocugen, Inc. Announces U.S. FDA Clearance of IND Amendment to Initiate OCU400 Phase 3 Clinical Trial — First Gene Therapy to Enter Phase 3 with a Broad Retinitis Pigmentosa Indication April 08, 2024 From Ocugen Via GlobeNewswire Why Ocugen Stock Is Climbing Today April 05, 2024 Ocugen shares are trading higher Friday after the company announced it has received approval to proceed dosing with the medium dose of OCU410 in the dose-escalation phase of its Phase 1/2 study. Ocugen... Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session April 05, 2024 Via Benzinga Ocugen Announces Positive Data and Safety Monitoring Board Review and Initiation of Enrollment in Medium Dose for OCU410—a Modifier Gene Therapy—in Phase 1/2 ArMaDa Study for Geographic Atrophy April 05, 2024 From Ocugen Via GlobeNewswire Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday April 03, 2024 U.S. stocks were higher, with the Dow Jones gaining over 50 points on Wednesday. Via Benzinga Topics Stocks Exposures US Equities OCUGEN ALERT: Bragar Eagel & Squire, P.C. is Investigating Ocugen, Inc. on Behalf of Ocugen Stockholders and Encourages Investors to Contact the Firm April 02, 2024 From Bragar Eagel & Squire Via GlobeNewswire Ocugen (OCGN) Q4 2023 Earnings Call Transcript April 02, 2024 OCGN earnings call for the period ending March 31, 2024. Via The Motley Fool Topics Earnings Exposures Financial OCGN Stock Falls Ocugen Must Restate Its Financials April 02, 2024 After an impressive rally to date, investors appear to be in selling mode with OCGN stock on the news it will need to restate its financials. Via InvestorPlace Ocugen Provides Business Update with Certain Financials for the Year Ending 2023 April 02, 2024 Conference Call and Webcast Today at 8:30 a.m. ET From Ocugen Via GlobeNewswire < Previous 1 2 3 4 5 6 7 8 9 ... 31 32 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.